Linden Thomas Advisory Services’s AbbVie ABBV Stock Holding History

Linden Thomas Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.78M	Buy	15,041 +710	+5%	+$153K	0.31%	80
2026 Q1	$3.12M	Buy	14,331 +824	+6%	+$183K	0.3%	95
2025 Q4	$3.09M	Buy	13,507 +407	+3%	+$92.7K	0.31%	86
2025 Q3	$3.03M	Buy	13,100 +152	+1%	+$31K	0.31%	83
2025 Q2	$2.4M	Buy	12,948 +561	+5%	+$104K	0.26%	112
2025 Q1	$2.6M	Buy	12,387 +49	+0.4%	+$9.53K	0.34%	81
2024 Q4	$2.19M	Buy	12,338 +35	+0.3%	+$6.43K	0.28%	113
2024 Q3	$2.43M	Sell	12,303 -37	-0.3%	-$6.91K	0.33%	79
2024 Q2	$2.12M	Sell	12,340 -217	-2%	-$35.9K	0.33%	82
2024 Q1	$2.29M	Buy	12,557 +94	+0.8%	+$16.2K	0.37%	62
2023 Q4	$1.93M	Buy	12,463 +121	+1%	+$17.6K	0.36%	72
2023 Q3	$1.84M	Sell	12,342 -14	-0.1%	-$2.06K	0.41%	56
2023 Q2	$1.66M	Buy	12,356 +345	+3%	+$50.6K	0.37%	73
2023 Q1	$1.91M	Buy	12,011 +1,194	+11%	+$183K	0.47%	47
2022 Q4	$1.75M	Buy	+10,817	New	+$1.66M	0.49%	53

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Linden Thomas Advisory Services's ABBV Position: Q2 2026 in Review

Linden Thomas Advisory Services increased its AbbVie (ABBV) stake by 5% in Q2 2026, buying an estimated $153K and bringing the position to 15,041 shares worth $3.78M. The position accounts for 0.31% of the portfolio, ranked #80.

Linden Thomas Advisory Services first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 1,482 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Linden Thomas Advisory Services held 15,041 shares of AbbVie worth $3.78M as of Q2 2026.
Linden Thomas Advisory Services bought 710 AbbVie shares in Q2 2026, an estimated $153K.
AbbVie made up 0.31% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #80 holding.
Linden Thomas Advisory Services first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
1,482 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.